Histopathological challenges in suspected drug-induced liver injury

Liver Int. 2018 Feb;38(2):198-209. doi: 10.1111/liv.13584. Epub 2017 Sep 19.

Abstract

When a patient with suspected drug-induced liver injury (DILI) undergoes liver biopsy, the pathologist is confronted with two major challenges. The first and most important is to establish the pattern(s) of injury which are present. Patterns of injury represent stereotypical responses of an organ to injury and relate to specific aetiologies of liver damage. The pattern of injury and the histological details of that injury can then be analysed with respect to the patient's intercurrent diseases and medication history. The specific expertise of the pathologist can be used to weigh the prospect of DILI against the likelihood of other explanations of injury. The second challenge is to characterize specific types of injury and the severity of injury, both of which may have importance for clinical decision-making and prognosis. The pathologist's report should convey both an accurate description of the pathology as well its interpretation.

Keywords: acute hepatitis; autoimmune hepatitis; cholestasis; hepatic necrosis; hepatotoxicity.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Biopsy
  • Chemical and Drug Induced Liver Injury / pathology*
  • Chemical and Drug Induced Liver Injury / therapy
  • Clinical Competence
  • Clinical Decision-Making
  • Diagnosis, Differential
  • Humans
  • Liver / drug effects*
  • Liver / pathology*
  • Pathologists
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors
  • Severity of Illness Index